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Abstract. The phosphorylation of regulatory myosin 
light chains by the Ca2÷/calmodulin-dependent enzyme 
myosin light chain kinase (MLCK) has been shown to 
be essential and sufficient for initiation of endothelial 
cell retraction in saponin permeabilized monolayers 
(Wysolmerski, R. B., and D. Lagunoff. 1990. Proc. Natl. 
Acad. Sci.  USA. 87:16-20).  We now report the effects of 
thrombin stimulation on human umbilical vein endo- 
thelial cell (HUVE) actin, myosin II and the functional 
correlate of the activated actomyosin based contractile 
system, isometric tension development. Using a newly 
designed isometric tension apparatus, we recorded 
quantitative changes in isometric tension from paired 
monolayers. Thrombin stimulation results in a rapid 
sustained isometric contraction that increases 2- to 
2.5-fold within 5 min and remains elevated for at least 
60 min. 
The phosphorylatable myosin light chains from 
HUVE were found to exist as two isoforms, differing in 
their molecular weights and isoelectric points. Resting 
isometric tension is associated with a basal phosphory- 
lation of 0.54 mol PO4/mol myosin light chain. After 
thrombin treatment, phosphorylation rapidly increases 
to 1.61 mol PO4/mol myosin light chain within 60 s and 
remains elevated for the duration of the experiment. 
Myosin light chain phosphorylation precedes the devel- 
opment of isometric tension and maximal phosphoryla- 
tion is maintained during the sustained phase of isomet- 
ric contraction. Tryptic phosphopeptide maps from 
both control and thrombin-stimulated cultures resolve 
both monophosphorylated Ser-19 and diphosphory- 
lated Ser-19/Thr-18  peptides indicative of MLCK acti- 
vation. 
Changes in the polymerization of actin and associa- 
tion of myosin II correlate temporally with the phos- 
phorylation of myosin II and development of isometric 
tension. Activation results in a 57% increase in F-actin 
content within 90 s and 90% of the soluble myosin II as- 
sociates with the reorganizing F-actin. Furthermore, 
the disposition of actin and myosin II undergoes strik- 
ing reorganization. F-actin initially forms a fine net- 
work of filaments that fills the cytoplasm and then reor- 
ganizes into prominent stress fibers. Myosin II rapidly 
forms discrete aggregates associated with the actin net- 
work and by 2.5 min assumes a distinct periodic distri- 
bution along the stress fibers. 
NDOTHELIAL cells lining most vessels form a continu- 
ous layer that normally constrains  proteins as well 
as formed blood elements to the vascular  lumen. 
The loss of continuity of the endothelial sheet leads to in- 
creased permeability and the development of edema (30, 
47, 51, 58, 71, 75). The increase  in microvascular  perme- 
ability by inflammatory and chemical mediators has been 
correlated with the presence of small gaps between adja- 
cent endothelial cells. Furthermore, mediators that disrupt 
actin  filaments  and  chelate  extracellular  calcium  have 
been implicated in changes in macromolecular flux. The 
factors that may play a role in altering the barrier function 
of the endothelium leading to edema include:  (a) loss of 
Address all correspondence to Robert B. Wysolmerski, Dept. of Pathol- 
ogy, St. Louis University Health Science Center, 1402 South Grand Blvd., 
St. Louis, MO 63104.Te1.: (314) 577-8497. Fax: (314) 268-5132. 
endothelial cell cohesion,  (b)  opening of tight junctions, 
(c) activation of intrinsic contractile activity, and (d) a dis- 
ruption of the constitutive balance between homotypic co- 
hesion,  junctional integrity, and basal contractile forces. 
The possibility that active contraction opens intracellular 
junctions resulting in edema was originally  proposed by 
Majno (51). Although several lines of evidence (41, 53, 60, 
73) are now available to support this argument, the intra- 
cellular events regulating endothelial cell contractile activ- 
ity remain to be elucidated. 
The dynamic assembly, disassembly, and reorganization 
of the actin and myosin II cytoskeleton are believed to me- 
diate a number of cellular contractile events in nonmuscle 
cells including endothelial cells. An understanding of the 
mechanism that regulates actin and myosin II cytoskeletal 
reorganization is fundamental to an understanding of en- 
dothelial cell contraction. We have used the phosphoryla- 
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traction as  a  model for endothelial cell contraction (73, 
74).  The  phosphorylation of myosin II  regulatory light 
chains by myosin light chain kinase  (MLCK)  1,  a  Ca2+/ 
calmodulin-dependent enzyme, is considered the essential 
requirement for activation both of smooth muscle (11, 19, 
23, 24) and nonmuscle cell contraction (6, 29, 48). Studies 
in vivo and vitro have shown that phosphorylation of non- 
muscle myosin II regulatory light chains by MLCK regu- 
lates the interaction of actin and myosin (2, 50), myosin II 
filament formation (12, 13, 27, 32), myosin ATPase activ- 
ity (1, 31, 33),  and in vitro motility (67).  Phosphorylation 
of the regulatory light chain has also been shown to ini- 
tiate cell retraction in permeabilized endothelial cells (73, 
74) and fibroblasts (6, 29, 42). 
We have previously shown that permeabilized endothe- 
lial  cell  preparations  use  a  smooth muscle-like  myosin 
based contractile system (73, 74). These preparations ex- 
hibited  thiophosphorylation of myosin light chains that 
was concomitant with retraction, and both the thiophos- 
phorylation and retraction were prevented by removal of 
MLCK and restored by replacement of purified MLCK to- 
gether with Ca2+/calmodulin. 
To further pursue the mechanism for endothelial cell re- 
traction, we  developed a  method to quantitatively mea- 
sure isometric contraction in tissue culture. This system al- 
lows  us  to  record  rapid  changes  in  basal  and  agonist 
stimulated tension over a period of hours to days. In this 
report, we present direct evidence in intact cells confirm- 
ing the results from permeabilized preparations showing 
that MLCK-mediated phosphorylation of myosin regula- 
tory light chains is tightly linked to initiation of endothelial 
cell retraction. Experiments have established a direct cor- 
relation  between  isometric  tension,  myosin  light  chain 
phosphorylation, actin polymerization, myosin II filament 
formation, and the spatial reorganization of the endothe- 
lial cytoskeleton. 
Materials and Methods 
Cell Culture 
Human umbilical vein endothelial cells (HUVE) were harvested from hu- 
man umbilical veins by the methods of Jaffe et al. (35). To eliminate con- 
taminating fibroblasts or  smooth muscle cells, primary HUVE isolates 
were seeded onto precast collagen gels prepared from a collagen/MCDB- 
107 solution composed of 4.0 ml bovine collagen (~3 mg/ml stock bovine 
calf skin collagen [Vitrogen Collagen Corp., Palo Alto, CA]), 4.4 ml 2 x 
MCDB-107, 1 ml FCS, 4 ml MCDB-107 containing 20% FCS, penicillin, 
streptomycin, and 0.4 ml 0.1 N NaOH. 15 ml of 1 mg/ml collagen/MCDB- 
107 was poured into a  100 x  20-ram Corning tissue culture dish and al- 
lowed to gel for 24 h  at 37°C in a  humidified incubator. Cells from six 
cords (average length 20 cm) were pooled and seeded onto the precast 
collagen gels in MCDB-107 medium supplemented with 20% FCS, 90 p,g/ 
ml heparin, 50 p.g/ml endothelial cell growth supplement (ECGS; Collab- 
orative Research, Inc., Waltham, MA), 5 p.g/ml transferrin, 5 ~g/ml insu- 
lin, 5 p,g/ml penicillin, and 50 U/ml streptomycin. HUVE formed a conflu- 
1. Abbreviations used in this paper: ECGS, endothelial cell growth supple- 
ment; HUVE, human umbilical vein endothelial cells; ITMA, isometric 
tension monitoring apparatus; MLC, myosin light chain; MLCK, MLC ki- 
nase; RSP, removable specimen platform; SB, stabilization buffer; TLCK, 
Na-p-tosyl-L-lysine chloro-methyl  ketone;  TPCK,  N-tosyl-L-phenylala- 
nine chlormethyl ketone. 
ent monolayer within 3-5 d  and were maintained at confluence for an 
additional 5 d in which time contaminating fibroblasts and/or smooth mus- 
cle cells invade and migrate to the bottom of the collagen gel. Monolayers 
were subcultured by soaking gels in Mg  2÷ Ca2+-free PBS containing 1 mM 
EGTA for 10 min followed by incubation with 10 ml of 0.05% collagenase 
(Type II; Worthington Biochemical Corp.,  Freehold,  NJ)  for 5  min at 
37°C. Large sheets of HUVE, which detach from the underlying collagen 
gel within 2-5 min, were transferred to 50-ml conical centrifuge tubes con- 
taining equal volumes of 0.125%  trypsin/EDTA for an additional 5-min 
incubation. After centrifugation, ceils were seeded onto either fibronectin 
coated (3.3 ixg/cm  2) 35 x  10-mm dishes for biochemical and morphologi- 
cal  studies or  directly  onto precast collagen gels for  tension measure- 
ments. Split ratios were determined such that cells were confluent when 
seeded. First passage HUVE monolayers 6 d after confluence were used 
throughout this study. 
Experimental Procedure 
24 h before experiments were performed, media was completely replaced 
with MCDB-107 containing 10% FCS and 5 ~g/ml transferrin. Thrombin 
was prepared  immediately before  use at  a  concentration of 1  U/ml in 
MCDB-107 containing 5  ~g/ml transferrin, 0.25%  BSA and was main- 
tained at 37°C. For most experiments unless otherwise noted, monolayers 
were briefly rinsed with MCDB-107 containing 0.25 % BSA and then incu- 
bated with thrombin for the following time periods: 0, 30, 60, 90 s, 2.5, 5, 
15,  30,  and 60 min in a  humidified 5%  CO2 atmosphere at 37°C.  The 
monolayers were  processed  according  to  the  individual  protocols  de- 
scribed below. 
Isometric  Tension Measurements 
A  newly designed tension apparatus that uses the same principles for 
HUVE isometric tension measurements as described previously (41) was 
used in the present study. The modified design allows us to perform simul- 
taneous tension measurements on two monolayers and to prepare mono- 
layers separate from the isometric tension apparatus. Fig.  1 A  is a  dia- 
grammatic representation of the modified horizontal isometric tension 
monitoring apparatus (ITMA). The tension apparatus is constructed of a 
24-gauge stainless steel base (24 x  28 cm) supported by three inch adjust- 
able legs. 20-mm round support rods are secured to the base and con- 
nected at the apex (long edge) by 7-mm stainless steel rods. These rigid 
cross bars are used to suspend both the isometric force transducers and x, 
y, z multiaxis stage manipulators. Research grade isometric force trans- 
ducers (model 52-9545;  Harvard Apparatus Co., S. Natick, MA) are af- 
fixed to the crossbar by two rack and pinion stages (Harvard Apparatus 
Co., catalog no. 50-2617).  Small adjustments can easily be made in the x, y 
direction with this configuration. Miniature x, y, z multiaxis stage manipu- 
lators (right and left handed; Stoelting Research Instruments, Wood Dale, 
IL) are attached to the opposite support column with 9.5-mm boss head 
clamps and two 20-cm stainless steel support rods. To prevent drifting of 
the x, y, z multiaxis stage manipulators over the duration of an experi- 
ment, the shafts of the micromanipulators are fitted with locking rings. 
An advantage of the current design is the capability to prepare  and 
grow monolayers unattached from the ITMA. Fig. 1 B is a schematic illus- 
tration of the removable specimen platform (RSP). This platform (125  x 
130  cm) is designed to accommodate two 100-ram polymethylpenthene 
petri dishes. On either side of the petri dish attached to the base of the 
RSP are two brass support posts (4 cm x  2 mm). An alligator clip (no. 12, 
archer) soldered to the end of a brass shaft is attached to the support post 
by a  10-ram boss head clamp. The alligator clips are used to immobilize 
and maintain a  fixed distance between the porous polyethylene holders 
thus reproducing the conditions under which monolayers are grown when 
attached to the ITMA (Fig. 1 A). This design prevents movement of the 
polyethylene  holders  as  monolayers  develop  a  stable  basal  tension. 
HUVE (3.5  x  106) were seeded onto the precast collagen gels (41) and 
maintained at  37°C in  a  humidified 5%  CO2  atmosphere. Monolayers 
were confluent within 3 d  and used after stabilization of basal isometric 
tension (~5-7 d  after confluence). Monolayers established on the RSP 
were maintained for 6 d  at 37°C in a  CO2 incubator before being trans- 
ferred to the ITMA. 
Transducers were calibrated with a series of weights ranging from 10 to 
500 dynes. To confirm that all of the recorded basal and stimulated ten- 
sion was produced by the cells, the following calibrations were performed 
on all monolayers: (a) 3 IxM cytochalasin D was added to abolish cellular 
tension and verify that tension was not attributed to the collagen matrix 
The Journal of Cell Biology, Volume 130, 1995  614 Figure 1.  (A). Schematic representation of the horizontal ITMA. The ITMA has been designed to perform simultaneous measurements 
on paired monolayers and to prepare monolayers unattached from the apparatus. Both the force transducers and x, y, z, multistage mi- 
cromanipulators are suspended from the rigid stainless steel cross supports by rack and pinion stages to facilitate attachment and align- 
ment of the holders. Two polymethylpentene petri dishes are secured to a RSP. Porous polyethylene holders are positioned in the petri 
dishes within a 25-mm trough cut into the silicon elastomer. Collagen is cast between the polyethylene holders and allowed to polymer- 
ize for 24 h  before.seeding HUVE.  (B). RSP allows monolayers to be prepared unattached from the ITMA. Platforms accommodate 
two polymethylene petri dishes. Porous polyethylene holders are placed within the petri dish and immobilized by alligator clips to pre- 
vent movement of the holders as the cells thin the collagen gel. Cell-populated collagen gels are cast identically to those prepared on the 
ITMA, maintained at 37°C for 6 d  in a CO2 incubator and transferred to the ITMA. 
and polyethylene holders; (b) collagen gels were removed from the poly- 
ethylene holders and transducer output was recorded with the free float- 
ing holder (this procedure ensures that there is no downward deflection 
from the polyethylene holders contributing to recorded tension); and (c) 
polyethylene holders were removed and transducer output was recorded. 
Tension was recorded using Modular Instruments Inc. (MI2; Modular 
Instruments Inc., Malvein, PA) bioreport software package. For all mea- 
surements, MI  2 tissue bath data acquisition parameters were set as fol- 
lows: (a) 2-s sample time, (b) frequency 32 hertz, and (c) sensitivity 0.3. 
Tension was recorded at 2-s intervals for the duration of all experiments. 
Cell Labeling 
For analysis of myosin phosphorylation, HUVE were labeled with either 
[35S]methionine  or [3~p]orthophosphoric acid or were double labeled with 
both.  Because  labeling monolayers in  either metliionine-free or  phos- 
phate-free media induces alterations in  basal HUVE isometric tension 
and labeling in phosphate-free media for 2.5 h induces a 10-15 _+ 5% in- 
crease in LDH release (45) above control cultures, the following labeling 
protocols were employed. To [35S]methionine  label cultures, HUVE were 
seeded at confluence in the presence of 25 ixCi/ml [aSS]methionine  in low 
methionine media (MCDB-107 containing 20 ixM methionine, 20%  me- 
thionine-free FCS, 75  ~g/ml ECGS,  and 90  p.g/ml heparin), and main- 
tained at confluence for 7 d. Monolayers were refed with low methionine 
media containing [aSS]methionine  every 3 d. 24 h  before an experiment, 
monolayers were washed twice with media and refed with low methionine 
MCDB-107 media supplemented with [aSS]methionine  and 10% methio- 
nine-free FCS only. 
To  label with [32P]orthophosphoric acid, cultures were washed twice 
with 2.5 ml of low phosphate media (MCDB-107 containing 20 IxM so- 
dium phosphate and 10% phosphate-free FCS) and then incubated with 2 
ml of 75 ixCi/ml [32P]orthophosphoric acid in low phosphate media for 3 h 
at 37°C in a humidified 5% COff95% air atmosphere. For double label ex- 
periments,  cultures  were  first  labeled  with  [35S]methionine  as  stated 
above, washed twice with low phosphate media, and then incubated with 
[32p]orthophosphoric acid as outlined above. 
For experiments, [35S]methionine-labeled cultures were washed with 
2.5 ml MCDB-107 containing 0.25% BSA and then incubated with 1 U/ml 
thrombin in MCDB-107 supplemented with 0.25% BSA for the indicated 
times.  Double  labeled  and  [32p]orthophosphoric  acid-labeled  cultures 
were washed in low phosphate MCDB-107 containing 0.25%  BSA and 
then incubated in this medium containing 1 U/ml thrombin and 75 p~Ci/ml 
[32p]orthophosphoric acid for the desired time intervals. 
Immunoprecipitation of  HUVE Myosin 
HUVE myosin II was immunoprecipitated by a modification of our previ- 
ously published methods (73). Experiments were terminated by aspirating 
media, flooding cultures with 600 ixl of buffer A (25 mM Tris-HCl pH 7.9, 
250  mM NaC1,  100  mM Na4P207,  75  mM NaF,  5  mM EGTA,  5  mM 
EDTA, 1% NP-40, 0.5% DOC, 0.2 mM PMSF, 0.5 mM DTT, 100 ~g/ml 
benzamidine, 100 p.g/ml soybean trypsin inhibitor, 10 p.g/ml of N-tosyl- 
L-phenylalanine chlormethyl ketone (TPCK), Nct-p-tosyl-L-lysine  chloro- 
methyl ketone (TLCK), aprotinin, leupeptin, pepstatin, and 15 mM mer- 
captoethanol at 4°C) and immediately placing them on a 4°C solid copper 
block.  Monolayers were  scraped up  with  a  rubber  policeman, culture 
dishes washed with an additional 100 p.1 of buffer A, samples combined 
and extracted on ice for 10 rain. The total cell extract was centrifuged at 
132,000 g for 10 min in a Beckman TL-100 ultracentrifuge. The superna- 
tants were removed and incubated with 20 Ixl of a polyclonal rabbit anti 
platelet myosin II IgG fraction (15 mg/ml) (74) for 3 h at 4°C. Initial stud- 
ies indicated that a variable degree of myosin II (ranging from 10 to 20% 
of total) remained associated with the 132,000-g pellet, so the cell pellets 
were extracted again by incubation in 200 pLl of buffer A  containing 600 
mM NaCI, 50 mM KI, sonicated in a bath sonicator for two 5-s bursts and 
incubated on ice for 20 min. The insoluble material was sedimented at 
132,000 g, extracts diluted with an equal volume of buffer A without NaC1 
or KI and then combined with the initial sample. After the 3-h incubation, 
prewashed protein A-Sepharose 4B was added for an additional hour. 
Immune complexes bound to protein A-Sepharose 4B were collected by 
centrifugation for 5 min at 12,000 g  at 4°C.  Pellets were first washed in 
1 ml of buffer A  then washed once with a  1:1 dilution of buffer A/PBS, 
twice with PBS, and finally once with a 1:1 dilution of PBS/distilled water. 
The pellets were dissolved in either 40 ~1 SDS sample buffer (44) or 100 p.l 
of IEF sample buffer (28). 
One- and Two-Dimensional  Electrophoresis 
One-dimensional SDS-PAGE was carried out in either 10% or 7.5-12% 
gradient vertical slab gels using the buffer system of Laemmli (44).  Gels 
were stained with Coomassie blue, destained, dried at 70°C and exposed 
to Kodak X-OMAT x-ray film or phosphor screens. 
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gel electrophoresis followed the methods described by O'Farrell (55) as 
modified by Ludowyke et al. (48). For first dimensional separation of my- 
osin light chains, IEF gels were prepared according to the procedure of 
Hochstrasser et al. (28). 
Apparent pI values of the HUVE myosin light chains were determined 
by cutting tube gels into 5-mm pieces and soaking each gel piece in i  ml of 
deionized, degassed water for 24 h. The pH of the solutions was measured 
using a Radiometer PHM 82 pH meter and the values plotted against dis- 
tance from the top of the gel. The distances of migration of the myosin 
light chain isoforms/phosphorylation states from [3sS]-labeled  cultures an- 
alyzed by two-dimensional electrophoresis were measured and pI values 
determined from the plot. The pI values were not corrected for the pres- 
ence of urea (18). 
Quantitative Analysis of HUVE Myosin Light 
Chain Phosphorylation 
The stoichiometry of HUVE myosin light chain phosphorylation was de- 
termined by two-dimensional electrophoresis of [35S]-labeled myosin light 
chains for direct estimates of the relative amounts of unphosphorylated, 
monophosphorylated, and diphosphorylated forms of myosin light chains 
present in control and thrombin treated monolayers. Scanned autoradio- 
grams or phosphor plates were analyzed using Molecular Dynamics Image 
Quant Software and the state of myosin fight chain phosphorylation calcu- 
lated and expressed as either percentage of total myosin light chain phos- 
phorylation or tool PO4/mol MLC. 
The mol/mol content was calculated from the following formula: 
M/M = P1 + 2(P2)/U +  P1 +  P2  (1) 
where U = % unphosphorylated, P1 = % monophosphorylated and P2 = % 
diphosphorylated HUVE myosin light chains. The diphosphorylated myo- 
sin light chain (P2) is multiplied by a factor of 2 to reflect the presence of 
two phosphate groups per light chain. The percentage of light chain phos- 
phorylation was calculated by adding the densitometric values for each 
phosphorylation state for each isoform, i.e., unphosphorylated (U1 +  U2), 
monophosphorylated (M1  +  M2)  and diphosphorylated (D1  +  D2)  (see 
Table If). 
One-Dimensional Tryptic Peptide Mapping 
[32p]orthophosphoric acid-labeled immunoprecipitates were  eleetropho- 
resed on 7.5-15%  gradient SDS-polyacrylamide gels that were fixed in 
50% methanol/10% acetic acid, dried at 70°C and exposed to x-ray film 
for detection of [32P]-labeled  myosin light chains. Labeled bands that cor- 
responded to the HUVE regulatory myosin light chains were cut from the 
SDS-polyaerylamide gel and digested with TPCK-treated trypsin as out- 
lined by Ludowyke et al. (48). 
Tryptic peptides of HUVE myosin light chains were separated follow- 
ing the methods described by Daniel and Sellers (14). Standards for one- 
dimensional tryptie peptide maps were generated by in vitro phosphoryla- 
tion of hUVE  myosin. Protein A  beads containing immune complexed 
HUVE myosin II were incubated with MLCK as outlined by Umemoto et 
al. (67) or with protein kinase C as described by Kawamoto et al. (40) for 
15 min at 30°C.  Phosphorylation was terminated by addition of 1 ml of 
PBS containing 25 mM EGTA (pH 7.4) followed by three 1-ml washes in 
PBS. Protein A~Sepharose beads were resuspended in 100 ~1 of SDS sam- 
ple buffer (44) and phosphorylated myosin If electrophoresed on 7.5-15 % 
gradient SDS-polyacrylamide gels. 
Actin Quantitation 
Monolayers were fixed in freshly prepared 3% formaldehyde in stabiliza- 
tion buffer (SB;  127 mM NaC1,  50 mM KCI, 1.1 mM NaH2PO4, 2 mM 
Mg2SO4,1 mM EGTA, 20 mM Pipes, 5.5 mM glucose, pH 6.5) at 37°C for 
10 min and for an additional 50 min at room temperature. The fixed cul- 
tures were washed twice with SB and then permeabilized in SB containing 
0.1%  NP-40, 0.05%  DOC for  15  min. Permeabilized monolayers were 
stained in the dark with 0.175  Ixg rhodamine phalloidin in PBS for 60 rain 
at room temperature and then gently washed three times with SB. Cul- 
tures were extracted with 1.5 ml of methanol for 2 h; cytoskeletons washed 
with an additional 0.5 ml methanol, samples combined, and rhodamine 
phalloidin content quantitated using a SLM 8100 fluorospectrophotome- 
ter (exitation 542 rim, emission 563 rim). 
To quantitatively express the changes in F-actin, it was necessary to 
compensate for variability in cell number among cultures. Previous studies 
(5, 22) have used ethidium bromide to stain cells and reported the differ- 
ence in fluorescent intensity per culture was a reflection of nuclear stain- 
ing, hence, variations in cell number. Our initial studies following pub- 
lished protocols (22) found ethidium bromide staining to be nonspecific. 
For these studies we used a DNA fluorochrome that is highly DNA spe- 
cific.  The probe is prepared following the methods outlined by Lundell 
and Hirsh (49). 
After methanol extraction of rhodamine phalloidin, monolayers were 
rehydrated in three washes of DPBS for a total of 15 rain. Cultures were 
then flooded with 1.5 ml of working fluoroprobe and endothelial cytoskel- 
etons  removed  from  the  dish with  a  rubber  policeman.  Dishes were 
washed with an additional 500 Ixl of the fluoroprobe, samples combined 
and sonicated in a bath sonicator for three 5-s bursts. Fluorescent intensity 
was measured with an SLM-Aminco 8100 fluorospectrophotometer (exi- 
tation 466 nm, emission 565  nm, bandpass of 4, 0.5 s integration, with a 
PMT setting of 600V). The fluorescence intensity (FI) was expressed as a 
ratio  of extracted  rhodamine phalloidin fluorescence to  DNA fluores- 
cence to correct for variation in cell number among cultures. Results are 
then expressed as relative  F-actin content  (RFC);  i.e.,  the ratio  of FI 
thrombin to FI control (RFC = FI thrombin/FI control). 
HUVE Myosin H Distribution 
Stimulation media was aspirated and cultures flooded with 1 ml of 37°C 
permeabilization buffer B  (20 mM Pipes, 10 mM Imidizole, 50 mM KCI, 
25 mM Na4P207, 25 mM NaF, 0.1% Triton X-00, 0.05% NP-40, 0.2 mM 
PMSF, 100  p~g/ml benzamidine, 100  ixg/ml soybean trypsin inhibitor, 10 
p~g/ml of TPCK, TLCK, aprotinin, leupeptin, and pepstatin pH 6.5) for 
30 s at room temperature. Buffer B (containing the soluble myosin II frac- 
tion) was then aspirated and spun at 12,000 g, 4°C for 2 rain to ensure re- 
moval of any floating ceUs. The recovered volume from each culture dish 
was determined and the differences in recovery corrected for before gel 
analysis. A  200-~1 aliquot was removed from the soluble myosin II frac- 
tion, added to 100 ~l of boiling 3× SDS sample buffer and heated at 100°C 
for an additional 5 min. The samples were subjected to SDS-polyacryl- 
amide gel electrophoresis in 7.5% vertical slab gels using the buffer sys- 
tem of Laemmli (44) and the proteins were transferred to 0.2-1xm nitrocel- 
lulose membrane at 90 mAmp at 4°C for 20 h  in 25 mM Tris, 192  mM 
glycine, 0.1% SDS, and 20% methanol, pH 8.3. Myosin II was detected by 
the ECL method (Amersham Corp., Arlington Heights, IL) using an af- 
finity-purified rabbit antibody to human platelet myosin II heavy chain. 
X-ray films were developed at various time intervals to obtain an expo- 
sure within the linear range of the film. Films were scanned in a personal 
densitometer (Molecular Dynamics, Sunnyvale, CA) in two dimensions; 
the densitometry units (DU) for each sample were standardized based on 
DNA content (see below) and expressed as a ratio of densitometric units 
to DNA content. Results are then expressed as relative myosin II content 
(RMIIC); i.e., DU thrombin to DU control. (RMIIC = DU thmr,  bjDU ~ont~ol)- 
DNA content was determined following a modification of the proce- 
dure described by West et al. (69). Following aspiration of buffer B, cul- 
tures were immediately flooded with 1.0 ml of 10 mM EDTA, pH 12.3, 
containing 50  i~g/ml RNase (DNase-free) and incubated at 37°C for 20 
min. After incubation cultures were cooled to 4°C on ice, cytoskeletons 
scraped up with a rubber policeman, and transferred to 13 ×  100-ram test 
tubes. Cultures were washed with an additional 400 ~l 10 mM EDTA, pH 
12.3,  samples combined, sonicated in a bath sonicator and 100  ~l of 1M 
KH2PO  4 added to neutralize the pH. For fluorometric determination of 
DNA, 1.5 ml of Hoechst 33258 (200 ng/ml in 100 mM NaCl, 10 mM Tris, 
pH 7.0) was rapidly added to each tube and gently vortexed. Fluorescence 
was measured using a fluorescence spectrophotometer (slit width 5, sensi- 
tivity 0.3, excitation 350 nm, and emission 455 nm; 650-10s; Perkin-Elmer 
Cetus Instrs., Norwalk, CT). Standards of salmon testes DNA were added 
directly to 1.4 ml of 10 mM EDTA, pH 12.3, incubated at 37°C for 20 min 
and treated identically to experimental samples. 
Immunofluorescence 
For  fluorescent staining, cells were  grown in  35  ×  10-ram fibronecfin 
coated  culture  dishes.  To  visualize  actin  microfilaments,  control  and 
treated monolayers were fixed with freshly prepared 3% formaldehyde in 
SB, pH 7.0,  stained with rhodamine phalloidin (Molecular Probes, Inc., 
Eugene, OR) by the method of Barak et al. (3), washed with PBS, and 
coverslipped in 90% glycerol/10% PBS containing 0.1M n-propyl gallate 
(20). For myosin fI staining, cultures were fixed in 37°C 1% formaldehyde 
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formaldehyde/SB containing 0.2% Triton X-100, 0.5% DOC for an addi- 
tional 60 min at room temperature. Cultures were gently washed in SB 
and  further permeabilized by incubation  in  0.4%  Triton  X-100,  0.6% 
DOC for 5 min. Monolayers were rinsed in SB and then incubated for 2 
min in 10 mM sodium borohydrate to reduce free aldehyde groups. Non- 
specific binding was  minimized by  incubation  of cultures  in  blocking 
buffer (PBS containing 0.8%  BSA, 0.1%  gelatin, 10 Ixg/ml normal goat 
IgG, pH 7.3) for I h at room temperature. HUVE were stained with an af- 
finity-purified rabbit anti-human platelet myosin II heavy chain antibody 
for 1 h  and then with affinity-purified rhodamine conjugated goat anti- 
rabbit IgG antibody for an additional 60 min. Cultures were washed in 
PBS  and  coverslipped with  90%  glycerol/10%  PBS  containing 0.1  M 
n-propyl gallate. Z-series were performed with a Bio-Rad MRC600 Con- 
focal Microscope and composite micrographs constructed. 
Affinity Antibody Purification 
A  rabbit polyclonal IgG fraction (15  mg/ml) that was reactive against 
HUVE myosin II heavy chains was purified against human platelet myo- 
sin II. Platelet myosin II (14)  (1 mg/ml) was coupled to cyanogen-bro- 
mide-activated Sepharose 4B (Sigma Chem. Co., St. Louis, MO) for 6 h at 
room temperature. After extensive washing and equilibration in PBS, rab- 
bit IgG diluted 1:1 with PBS, pH 7.5, was applied to the myosin II affinity 
column. The antibody was recycled twice through the column. Beads were 
washed with PBS containing 0.4 M NaC1, equilibrated in PBS and then 
eluted with 0.2 M glycine, pH 3.0; followed by 1 bed vol of distilled water. 
Eluted fractions were brought to pH 7.0 with 1 M Tris pH 9.0, concen- 
trated and dialyzed against PBS, pH 7.3, containing 1 mM NAN3. Affinity- 
purified antibodies were stored at -70°C. 
Results 
Isometric Tension 
The present study uses a second generation isometric ten- 
sion apparatus (Fig. 1 A) that permits simultaneous mea- 
surements on two monolayers as well as multiple measure- 
ments (8 per week) because of the ability to prepare and 
maintain  monolayers separate  from the  ITMA.  The  re- 
movable  specimen  platform  (Fig.  1  B)  was  constructed 
such that the porous polyethylene holders are immobilized  s0 
by alligator clips so that HUVE cells seeded onto precast 
collagen  gels  can  compress the  collagen  gel  into  a  thin 
70 
membrane over the period of days needed to establish a 
stable basal tension. Without immobilization of the poly-  60 
ethylene holders, cell-populated ridges form in the center 
of the collagen gel as the endothelial cells compress and 
A  50  thin the gel, and with time the holders are pulled together. 
With the new design, monolayers grown on the RSP de- 
velop the same basal tension as those grown attached to  2  40 
the ITMA and they can be transferred and attached to the 
x, y, z  micromanipulators and force transducers  without  so 
slacking  or  stretching  of  the  monolayers,  changes  that 
have been found to alter the response of HUVE monolay-  20 
ers to vasoactive mediators (unpublished observations).  1 
Precast collagen gels prepared on either the ITMA or  40 
the RSP were seeded with HUVE cells at densities  that 
formed a confluent monolayer within 6 h and compressed  0 
the collagen gel into a thin membrane over the following  0 
2-3 d. A  stable isometric tension of 30-35 dynes (33 +_ 3.5, 
n  =  9) developed within 5-6 d of confluence and remained 
stable for up to 21 d. Monolayers were used within 24 h of 
reaching a steady basal tension (typically 8 d after seeding) 
however, no variation in response was detected in mono- 
layers used up to 10-15 d after seeding. After stimulation, 
monolayers were washed with MCDB-107 containing 0.25 % 
BSA and basal tension was allowed to restabilize for 60 rain. 
Fig. 2 depicts a typical tracing of isometric tension produced 
by a HUVE monolayer exposed to 1 U/ml thrombin. Iso- 
metric tension  developed rapidly within the  first minute 
and reached a peak of 59 dynes by 5 min. Peak tension was 
maintained for 50 min before slowly declining over the fol- 
lowing 60 min. Although the time course and magnitude of 
tension development was consistent among preparations, 
variations occurred in the duration of maximally sustained 
tension.  Thrombin  treated  monolayers  achieved  a  peak 
tension of 60.5  ___ 4.5  (n = 9) dynes within 5 min while the 
duration  of sustained  tension  varied from 50 to 80 rain. 
Addition of 3  p~M cytochalasin D  at any time during the 
experiment rapidly  abolished  the  isometric tension  pro- 
duced by the monolayers. No differences in tension devel- 
opment were evident when using monolayers grown exter- 
nal to the ITMA. 
HUVE Myosin Light Chain Phosphorylation and 
Isometric Tension Development 
For determination of the dose dependence of thrombin in- 
duced  myosin light chain phosphorylation, cultures were 
labeled  with  [32p]orthophosphoric  acid,  incubated  with 
various concentrations of thrombin for 5 min and myosin 
II  immunoprecipitated  and  the  extent  of  myosin  light 
chain  phosphorylation  assessed  as  described  previously 
(73). Thrombin treatment results in a dose-dependent in- 
crease  in  myosin  light  chain  phosphorylation  (data  not 
shown). A 1.7-fold increase in myosin light chain phosphor- 
ylation occurred with 0.1 U/ml thrombin and phosphoryla- 
tion increased with each successive dose reaching maximal 
levels, over three times that of controls, at 0.75 U/ml throm- 
bin. No significant increase in myosin heavy chain phos- 
phorylation was detected over control cultures  (data not 
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Figure 2.  Representative tracing  of isometric tension produced 
by HUVE exposed to 1 U/ml thrombin. Thrombin causes a rapid 
rise in tension reaching a peak of 59 dynes. Peak tension is main- 
tained for 50 rain  before slowly declining  over the ensuing  60 
min. Treatment with 3 I~M cytochalasin D abolished tension within 
5 min. 
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bin was chosen for all experiments. The doses of thrombin 
found to elicit an increase in light chain phosphorylation 
are within the range observed during blood clotting (61) 
implicating thrombin as a potential physiological mediator 
of endothelial cell contraction. 
To  characterize  myosin  light  chain  phosphorylation 
induced  by  thrombin  in  HUVE  cells,  two-dimensional 
electrophoretic studies were performed. In the first set of 
experiments, monolayers were labeled with either [35S]me- 
thionine or double labeled with [35S]methionine and [32p]_ 
orthophosphoric  acid  as  outlined  under  Materials  and 
Methods. Cultures were stimulated for the desired time in- 
tervals, myosin II immunoprecipitated and then separated 
by two-dimensional gel electrophoresis with IEF (pH 4--6) 
in the first dimension and SDS-PAGE in the second dimen- 
sion. SDS-PAGE gels were dried and exposed to phosphor 
screens. Fig. 3, A  and B  show images of immunoprecipi- 
tated myosin II from a double labeled culture illustrating 
the  separation  of unphosphorylated and phosphorylated 
forms of HUVE  myosin light chains.  To distinguish  be- 
Figure S.  Phosphor images demonstrating  two-dimensional  gel 
electrophoretic separation  of unphosphorylated  and phosphory- 
lated isoforms of HUVE myosin light chains. Cells were labeled 
with both [35S]methionine  and [32p]orthophosphoric acid, stimu- 
lated with 1 U/ml thrombin for 2.5 min at 37°C and myosin II im- 
munoprecipitated  as described in Materials and Methods. Myosin 
II was then subjected to IEF (pH 6-4) in the first dimension and 
15% SDS PAGE in the second dimension. (A) SDS PAGE gel 
exposed to a phosphor screen through a copper foil to block beta 
emissions allowing discrimination between [32p]_ and [35S]-labeled 
light chains. Two [32p]-labeled  myosin light chain isoforms are de- 
tectable and exist in two phosphorylation states: monophosphor- 
ylated (M1, M2) and diphosphorylated  (D1, D2). (B) Direct expo- 
sure of the SDS PAGE gel to the phosphor screen detects both 
[32p]. and [35S]-labeled  myosin light chains. Two isoforms exist in 
unphosphorylated  (U1, U2), monophosphorylated  (1141, M2) and 
diphosphorylated  (D1, D2) states with distinct isoeletric points. In 
addition, the two [35S]-labeled nonphosphorylatable  (NP1, NP2) 
myosin light chains were detected. Double labeling of cells and 
differential  detection of radiolabeled  proteins allows for direct 
identification  of the relative  mobility of the three myosin light 
chain phosphorylation states. 
tween the [32p]_ and [35S]-labeled  light chains, SDS PAGE 
gels were exposed to the phosphor screen as follows: (a) a 
copper foil (0.0014 in thick; All-Foils, Brooklyn Heights, 
Ohio) was placed between the dried gel and the phosphor 
screen effectively blocking the beta emissions and allow- 
ing detection of only the [3zp]-labeled light chains (Fig. 3 
A) and (b) gels were reexposed directly to phosphor plates 
to detect both [32p]_ and  [35S]-labeled  light chains (Fig. 3 
B). By double labeling myosin II and differentially expos- 
ing the same gel, we were able to identify without ambigu- 
ity the unphosphorylated and phosphorylated myosin light 
chains.  Fig. 3 A  shows the presence of two [32p]-labeled 
myosin light chain isoforms (M1, Me; D1, D2)  that corre- 
spond to the 18- (M2, D2) and 19-kD (MI, D1) light chains 
each of which  exists  in  two  phosphorylation states,  i.e., 
monophosphorylated and  diphosphorylated.  The  mono- 
phosphorylated light  chains  focus closer to  the  cathode 
(M1, M2) and the diphosphorylated to the anode (D1, D2). 
Fig. 3 B  is a direct exposure of the same gel that detects 
both [32p]. and [35S]-labeled light chains. In addition to the 
phosphorylated light chains, this image shows the unphos- 
phorylated  forms  of  each  myosin  light  chain  isoform 
(U1,U2) that separate as the most basic proteins. The non- 
phosphorylatable  light  chains  (NP)  were  also  detected; 
these also exist as isoforms and have molecular masses of 
16 (NP1) and 15.5 kD (NP2). The apparent isoelectric points 
of the phosphorylatable and nonphosphorylatable myosin 
II light chain isoforms are listed in Table I. 
After establishing  the  relative positions  and  apparent 
isoelectric  points  of  unphosphorylated  and  phosphory- 
lated myosin light chains,  changes in phosphorylation of 
[35S]methionine-labeled myosin  light  chains  were  calcu- 
lated to determine the stoichiometry of thrombin induced 
phosphorylation. Fig.  4  illustrates  representative autora- 
diograms  from  selected  time  intervals  after  stimulation 
with 1 U/ml thrombin. Autoradiograms (Fig. 4) or phos- 
phor images were analyzed by two-dimensional laser den- 
sitometry and  the  relative proportions  of unphosphory- 
lated,  monophosphorylated,  and  diphosphorylated  light 
chains determined as a percent of the total. The extent of 
myosin light chain phosphorylation was also calculated as 
moles of phosphate incorporated per mole of light chain. 
Quantitative data from six time course experiments is pre- 
sented in Table II. In unstimulated cultures (Fig. 4 A, Ta- 
ble II), 57% of myosin light chains are unphosphorylated, 
32% are monophosphorylated, and 11% are diphosphory- 
Table I. Apparent Isoelectric Points of HUVE Myosin Light 
Chain Isoforms 
Unphosphorylated 
U2 
Ul 
Monophosphorylated 
M2 
M1 
Diphosphorylated 
D2 
D1 
Nonphosphorylatable 
NP2 
NP1 
5.11 
5.07 
5.04 
5.01 
4.99 
4.95 
4.86 
4.77 
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analysis of myosin light chain 
phosphorylation  from  con- 
trol (A) and thrombin stimu- 
lated (B-E) cultures. HUVE 
cells  were  labeled  with 
[35S]methionine as described 
in  Materials  and  Methods 
and  incubated  with  1  U/ml 
thrombin  for  30  s  (B),  2.5 
min (C), 30 min (D), and 60 
min (E).  Myosin  II was im- 
munoprecipitated  and  ana- 
lyzed  by  two-dimensional 
electrophoresis to determine 
the change  in unphosphory- 
lated  and  phosphorylated 
forms  of  HUVE  myosin 
light  chain isoforms.  Repre- 
sentative  time  points  illus- 
trating major shifts  in phos- 
phorylation  states  are 
presented. Quantitative data 
from the  entire time course 
of myosin light  chain  phos- 
phorylation  is  presented  in 
Table II. Only those portions 
of the  gels  that  include  the 
regulatory and essential light 
chains are shown. 
lated. After 30 s (Fig. 4 B, Table II) of thrombin stimula- 
tion, the amount of unphosphorylated light chains decreased 
to  16%  while  the  monophosphorylated and  diphosphor- 
ylated increased to 45 and 39%, respectively. By 60 s (Fig. 
4  C,  Table  II) maximal levels  of phosphorylation  were 
achieved with 66% of the myosin light chains diphosphor- 
ylated, 29% monophosphorylated, and only 5% remaining 
unphosphorylated. This level of phosphorylation was main- 
tained up to 30 min (Fig. 4 D, Table II) after the addition 
of thrombin. After 60 min (Fig. 4 E, Table II) in the con- 
tinued  presence  of  thrombin,  diphosphorylated  myosin 
light chains fell to 48% with concomitant increases occur- 
ring in both the mono- and unphosphorylated states; this 
represents  a  12.5%  reduction  in  light  chain  phosphory- 
lation. Analysis of the 18- and 19-kD light chain isoforms 
revealed no significant difference between their time course 
and extent of phosphorylation. 
Fig. 5 compares the stoichiometry of myosin light chain 
phosphorylation with tension development. The mean re- 
sults of six different experiments are presented. Basal ten- 
sion is associated with 0.54  _-_ 0.06 tool PO4/mol of MLC. 
Maximal phosphorylation of 1.61  +_. 0.12 mol POa/mol of 
MLC occurs within 60 s while tension develops more grad- 
ually reaching maximal levels by 5 rain. The rise in tension 
parallels  the  rise  in  phosphorylation  although  maximal 
phosphorylation  precedes maximal tension  development 
Table II. Distribution  and Stoichiometry of  Myosin Light Chain Phosphorylation  in Control and Thrombin 
Stimulated HUVE Monolayers 
Cont  30 s  60 s  2.5 min  15 min  30 rain  60 min 
Unphosphorylated (U1  +  U2)  57 ±  5  16 ±  6  5  ±  2  8  -  5  12 ±  5  12 ±  7  23 ±  8 
Monophosphorylated (M~ +  ME)  32_+5  45---5  29±7  24±11  24±8  21±6  29~2 
Diphosphorylated (D1  +  D2)  11  _+ 2  39 ±  2  66 ±  10  68 ±  13  64 ±  13  67 ±  9  48 ___ 9 
mol PO4/mol MLC  0.54 ±  0.06  1.23 ±-_ 0.07  1.61  ___ 0.12  1.59 ±  0.17  1.53 ±  0.18  1.56 ±  0.15  1.25 ±  0.17 
Cultures were labeled with [35S]methionine, stimulated with thrombin, and myosin II immunoprecipitated.  The light  chain isoforms/phosphorylation  states were separated by two- 
dimensional  electrophomsis  and the percentage of unphosphorylated (Uz +  U2), monophosphorylated (M I +  M2), and diphosphorylated (D  l + I)2) myosin light  chains determined 
by laser densitometric scans of antoradiograms (Fig. 4) or phosphor image analysis. The stoichiometry  of myosin light chain phosphorylation (mol phosphate/mol MLC) was cal- 
culated from the percentage of monophosphorylated and diphosphorylated  myosin light  chains as described in Materials and Methods.  Each point is the mean -+ SE of six separate 
experiments. 
Goeckeler and Wysolmerski Endothelial Contraction and Myosin Phosphorylafion  619 70 
60 
50 
==30 
I-- 
20 
10 
0  / 
Tension 
~  nr~le PO  4/mole MLC 
.  1,8 
! 
....  ~  1.6 
1.2 
~E 
1.0 
E 
lob  •- 
°.6  ~ 
0.4 
0.2 
,  ....  ~  ~-~---~  ~  0.0 
10  20  30  60 
Time (minutes) 
Figure 5.  Time course of isometric tension and stoichiometry of 
myosin light  chain  phosphorylation  upon  exposure  to  1 U/ml 
thrombin.  The extent of tension  (Fig. 2)  and phosphorylation 
(Fig. 4, Table II) were determined at 30 and 60 s, 2.5, 15, 30, and 
60 min. The increase  in phosphorylation  (mol PO4/mol MLC) 
precedes the development of isometric tension, but by 60 s phos- 
phorylation  parallels  tension  development.  Myosin light  chain 
phosphorylation  peaks at 60 s and remains elevated during the 
sustained phase of isometric tension. By 60 min, both tension and 
myosin light chain phosphorylation  begin to decline with phos- 
phorylation  declining more rapidly than tension.  Each point is 
the mean -+ SE of six separate experiments. 
(Fig.  5).  Maximal  phosphorylation  and  tension  were 
achieved within 5 min and remain at peaked levels for 30 
rain. By 60 min, both tension and phosphorylation begin to 
decline  with  phosphorylation  decreasing  more  rapidly 
than tension. 
Identification  of  Phosphorylation  Sites in HUVE 
Myosin Light Chains 
To determine if MLCK or PKC was responsible for the 
thrombin induced increase in myosin light chain phosphor- 
ylation, the sites of in vivo phosphorylation were analyzed 
by one-dimensional tryptic phosphopeptide mapping. For 
a direct comparison, HUVE light chains were phosphory- 
lated in vitro by either MLCK (Fig. 6, lane 1) or by PKC 
(Fig. 6, lane 5). The in vitro phosphorylated HUVE light 
chains were then subjected to the same tryptic digestion as 
thrombin stimulated  samples.  Fig.  6 illustrates the phos- 
phopeptide map of thrombin induced phosphorylated my- 
osin light chains (lanes 2--4) and the in vitro phosphory- 
lated standards  (lanes 1  and 5).  The tryptic map  of the 
MLCK phosphorylated standard (lane 1) consisted of two 
phosphopeptides. MLCK phosphorylated Ser-19 that cor- 
responds to the lower more basic phosphopeptide present 
in lane 1. In addition, MLCK phosphorylated Thr-18 re- 
sulting in a diphosphorylated peptide (Ser-19/Thr-18) that 
migrates to a more acidic position on the one-dimensional 
IEF gel. The tryptic map of the PKC phosphorylated HUVE 
myosin light chain standards (Fig. 6, lane 5) revealed three 
phosphopeptides. The two acidic peptides designed as Ser-l' 
and  Ser-1  have  been  shown  to  consist  of the  following 
sequences;  Ser-l'  =  N-acetyl-Ser-Ser-Lys and  Ser-1  = 
Figure  6.  One-dimensional 
tryptic  peptide  map  of 
HUVE  myosin  light  chain 
phosphorylation sites. Mono- 
layers  were  labeled  with 
[32p]orthophosphoric  acid; 
myosin  II  was  immunopre- 
cipitated  from control (lane 
2)  and  stimulated  cultures 
(lanes 3 and 4), digested with 
trypsin, and labeled  phosphopeptides  separated  by one-dimen- 
sional  isoelectric  focusing  gel  electrophoresis.  HUVE  myosin 
light chains were phosphorylated in vitro by MLCK (lane 1) or by 
PKC (lane 5) and used as standards. Ser-19 and Thr-18, (lane 1) 
are sites for MLCK phosphorylation, while Set-l, Ser-l' and Thr-9 
(lane 5) are sites phosphorylated  by PKC. Myosin light chains 
from control cultures exhibit constitutive phosphorylation at Ser- 
19 and Ser-19/Thr-18 sites that correspond to MLCK phosphory- 
lation. Furthermore, myosin light chains from cultures incubated 
with thrombin for 2.5 min (lane 3) and 60 min (lane 4) are phos- 
phorylated at Ser-19 and Ser-19/Thr-18. No PKC (lane 5) phos- 
phorylation was detected in control or stimulated cultures. Lane 
1:  in  vitro phosphorylation  of HUVE  myosin light  chains  by 
MLCK; lane 2: in vivo phosphorylation from control monolayers; 
lanes 3 and 4: in vivo phosphorylation  from HUVE monolayers 
stimulated  with  thrombin;  lane  5:  in  vitro  phosphorylation  of 
HUVE myosin light chains by PKC. 
N-acetyl-Ser-Ser-Lys-Arg (14, 54). PKC phosphorylation 
of the Thr-9 corresponds to the most basic phosphopep- 
tide in lane 5. 
Tryptic phosphopeptides obtained from control (lane 2) 
and stimulated monolayers (lanes 3 and 4) comigrated with 
the bands produced by phosphorylation of HUVE myosin 
light chain standards by MLCK (lane 1). Unstimulated cul- 
tures exhibited basal phosphorylation that corresponds to 
both monophosphorylated (Ser-19) and diphosphorylated 
(Ser-19/Thr-18) phosphopeptides. Stimulation with i  U/ml 
thrombin for 2.5 min (lane 3) or 60 min (lane 4) produced 
increases in [32p] incorporation into both phosphopeptides 
although the largest increase occurs in  the diphosphory- 
lated  peptide  (Ser-19/Thr-18).  Phosphopeptides  corre- 
sponding to the residues phosphorylated by PKC were not 
detected in either control or stimulated monolayers. Quali- 
tatively the data obtained by one-dimensional tryptic pep- 
tide mapping is in agreement with the analysis of myosin 
light chain phosphorylation states obtained by two-dimen- 
sional analysis of [35S]methionine-labeled monolayers (Ta- 
ble II). 
Thrombin Stimulated Reorganization  of  Actin 
and Myosin H 
After demonstrating that the increase in isometric tension 
in thrombin stimulated HUVE monolayers parallels myo- 
sin light chain phosphorylation, confocal microscopy was 
used to examine the morphological changes in F-actin and 
myosin II. Monolayers were treated with 1 U/ml thrombin 
for various times, were fixed and stained for F-actin with 
rhodamine phalloidin or for myosin II with affinity-puri- 
fied rabbit anti-human platelet myosin II heavy chain an- 
tibody as  outlined  under Materials  and  Methods.  Fig.  7 
shows  Z-series  composite  micrographs  of  control  and 
thrombin  stimulated  HUVE  monolayers. Fig.  7 A  illus- 
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distribution from control monolayers grown on fibronec- 
tin-coated culture dishes. Monolayers consist of a cohesive 
sheet of polygonal cells exhibiting a  thin rim of F-actin 
staining at their margins. HUVE are devoid of prominent 
stress fibers. However, most cells contain a few randomly 
dispersed fibers, while myosin II (Fig. 7 G) is diffusely lo- 
calized throughout the cytoplasm with no obvious organi- 
zation. With thrombin stimulation, both F-actin and myo- 
sin  II  undergo  rapid  and  striking  redistribution.  Fig.  7 
shows the F-actin (B-F) and myosin II (H-L) distributions 
in HUVE monolayers treated with 1 U/ml thrombin for 30 
and 60 s, 2.5, 30, and 60 min, respectively. By 30 s (Fig. 7 
B), a fine latticework of F-actin is evident throughout the 
cell cytoplasm. Distinct margins that delineate cells are no 
longer evident as the monolayer assumes the appearance 
of a contiguous meshwork of filaments. Myosin II (Fig. 7 
H) changes from the diffuse amorphous distribution present 
in control cells and organizes into discrete aggregates dis- 
persed randomly throughout the cytoplasm. By 60 s (Fig. 7 
C), the underlying latticework of F-actin is still present but 
organizing stress fibers begin to predominate. Myosin II 
(Fig. 7/) still localizes as discrete aggregates although there 
appears to be a more intense generalized staining than is 
seen at 30 s. 
By 2.5 min (Fig. 7 D) the actin filaments form an inter- 
connecting cross-linked network of stress fibers that fills 
the cytoplasm. The filaments appear to radiate from dis- 
crete foci (arrows) of condensed F-actin localized at cell 
margins. Myosin II (Fig. 7 J) colocalizes to actin filaments 
and exhibits a periodic distribution. Concentrations of my- 
osin II are evident at the cell margins (arrows) and coin- 
cide with foci of condensed F-actin filaments. After 30 min 
(Fig. 7 E), the actin has reorganized into prominent stress 
fibers aligned parallel to each other and to the long axis of 
the cell. Cells have retracted from one another, exhibiting 
small gaps between adjacent cells while retaining their po- 
lygonal morphology. Contracted HUVE cells remain at- 
tached to one another by slender cell processes containing 
F-actin filaments. In many areas, the stress fibers appear 
to be contiguous between adjacent cells. This same reorga- 
nized actin configuration is detected after 60 min of stim- 
ulation (Fig. 7 F). HUVE myosin II associates in a peri- 
odic  band-like  pattern  with  the  underlying  actin  stress 
fibers at both 30 (Fig. 7 K) and 60 min (Fig. 7 L). The inset 
in Fig. 7 L clearly illustrates the sarcomeric-like myosin II 
distribution in stimulated cells. In most cells, myosin II is 
excluded from the peripheral cytoplasm and the majority 
of slender actin containing cell processes that connect ad- 
jacent cells. 
HUVE F-actin content was then quantitated by metha- 
nol extraction of rhodamine phalloidin stained  cultures. 
Actin was  standardized  to  DNA  content to  correct for 
variations in cell number among dishes and experiments. 
Fig. 8 illustrates the time course of thrombin induced in- 
creases in F-actin content. Thrombin stimulated actin po- 
lymerization rapidly  increased  by 20%  within  30  s  and 
achieved maximal levels 58% above unstimulated controls 
within 90 s. A  slight drop in total F-actin content was de- 
tected at 5 min, however these levels were maintained at 
30 rain. By 60 min a 12% reduction in total F-actin content 
was seen. 
Redistribution of HUVE myosin II to the detergent in- 
soluble cytoskeleton paralleled changes that occurred in 
total F-actin.  Thrombin  stimulated  cells were  extracted 
with buffer B  and the myosin II in the detergent soluble 
fraction (cytoplasmic) was  quantitated by Western blot- 
ting. Detergent insoluble fractions (cytoskeleton) were ex- 
tracted with 10 mM EDTA, pH 12.3,  and DNA content 
measured as described under Materials and Methods. In 
unstimulated HUVE cultures, 88 ± 2.8% (n = 7) of the to- 
tal cellular myosin was present in the detergent soluble or 
cytoplasmic fraction. In all experiments, the cytoplasmic 
myosin II value in unstimulated cultures was designated as 
1.0 and the loss of myosin II from this fraction was used as 
a measure of myosin II association with the detergent in- 
soluble  fraction.  This  was  confirmed in  several  experi- 
ments by either quantitating both cytoplasmic myosin II as 
well as cytoskeletal associated myosin II or by immunoflu- 
orescent staining of myosin II. All data was normalized to 
total DNA content. Fig. 9 shows the time course of the 
change  in  cytoplasmic  myosin !I  following  stimulation 
with 1 U/ml thrombin. Within 30 s, 73% of myosin II was 
no longer present in the detergent soluble fraction. Maxi- 
mal redistribution (95%) of myosin II occurred by 5 min. 
The  myosin II  in  the  detergent  soluble  fraction subse- 
quently increased 22% over the ensuing 55 rain. 
Discussion 
Active contraction of endothelial cells was first suggested 
by Majno et al. (51) in 1969 as the mechanism responsible 
for the  permeability edema induced by histamine.  Our 
previous studies provided evidence for Majno's hypothesis 
by demonstrating that endothelial cell retraction required 
permissive levels of ATP (72) and was associated with my- 
osin light  chain phosphorylation (73,  74).  These studies 
also showed that removal or inhibition of MLCK in per- 
meabilized preparations  prevented retraction that  could 
then  be  rescued  by the  addition  of exogenous MLCK, 
Ca  2+ and calmodulin (73). More recently in intact mono- 
layers, we have shown that HUVE exposed to thrombin 
produce isometric tension (41). In this study, we demon- 
strate that isometric tension development correlates with 
myosin II light chain phosphorylation and is accompanied 
by polymerization and extensive reorganization of acdn as 
well as association of myosin II with the detergent insolu- 
ble cytoskeleton. Furthermore, thrombin-induced myosin 
light chain phosphorylation is catalyzed by MLCK. 
Experiments  documenting  tension  development  were 
performed on a  second generation isometric monitoring 
apparatus. The design of the external specimen platform 
had to permit immobilization of the porous polyethylene 
holders to (a) prevent movement during basal tension de- 
velopment and (b) allow transfer to the ITMA without re- 
leasing  developed tension  or  stretching  the  monolayer. 
Recent studies have documented the effects of stretch or 
stress relaxation on activation of Ca  2+ channels (46, 70), 
actin polymerization (56, 63) and cAMP/PKA (26) signal- 
ing pathways. Consistent with these studies, we found that 
a moderate 5-dyne stretch induced actin polymerization in 
HUVE monolayers that takes 4-6 h to return to baseline 
and that movement of the collagen gel during basal ten- 
sion development caused inconsistent results with agonist 
Goeckeler  and Wysolmerski  Endothelial  Contraction and Myosin Phosphorylation  621 Figure 7.  Immunofluorescent labeling in control and thrombin stimulated HUVE monolayers. Time course of redistribution of F-actin 
(A-F) and myosin II (G-L) upon exposure to 1 U/ml thrombin for 30 s (B and H), 60 s (C and/), 2.5 min (D and J), 30 min (E and K), 
and 60 min (F and L). F-actin was visualized by rhodamine phalloidin binding and myosin II was localized with affinity-purified anti- 
platelet myosin II antibodies as outlined in Materials and Methods. F-actin (A) and myosin II (G) distribution in unstimulated monolay- 
ers. A rim of F-actin staining is present at the cell margins with few randomly disoriented stress fibers within the cytoplasm. Myosin II is 
diffusely localized within the cytoplasm exhibiting no organized pattern. Upon thrombin stimulation, both F-actin (B-F) and myosin II 
(H-L) undergo progressive redistribution forming highly organized filamentous networks. Bar, 10 txm. 
stimulation (unpublished observations). Cells seeded onto 
precast collagen gels develop a stable basal isometric ten- 
sion within 5-6 d that is associated with constitutive light 
chain phosphorylation of 0.54  ___ 0.06 mol PO4/mol MLC. 
An increase in tension is detected within the first 30 s after 
thrombin stimulation reaching maximal levels within 5 min 
and maximal myosin II light chain phosphorylation (1.61 
___ 0.12 mol POa/mol MLC) occurs at 60 s, preceding maxi- 
mal  tension  development.  Maximal  phosphorylation  is 
maintained  throughout the  sustained  phase  of isometric 
tension, and a decline in phosphorylation parallels the de- 
crease in isometric tension. These data suggest that increases 
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in myosin II light chain phosphorylation  initiate  and sus- 
tain HUVE isometric tension. 
Quantitation  of the phosphorylation  states of myosin II 
light  chains  was  performed  by  two-dimensional  (IEF/ 
PAGE)  gel electrophoresis.  We found that  HUVE phos- 
phorylatable and nonphosphorylatable myosin light chains 
both consist of two isoforms with distinct molecular masses 
and isoelectric points (Table I). Isoforms of the phosphor- 
ylatable light chains have been identified in both smooth 
muscle (16, 39) and nonmuscle myosin (17, 40, 65). More 
recently,  the  cloning  of  cDNAs  has  been  reported  for 
smooth muscle and nonmuscle  myosin (21, 43, 64). Both 
isoforms  contain  phosphorylation  sites  for  both  MLCK 
(Ser-19, Thr-18) and PKC (Ser-1, Ser-2, Thr-9) and since a 
high  degree  of homology exists between  these  isoforms, 
they are likely to be regulated in a similar fashion. In the 
present study, there was no significant difference in the de- 
gree  of phosphorylation  between the  HUVE  light  chain 
isoforms.  Although  the  functional  significance  of  these 
light chain isoforms is not known, they may be associated 
with specific heavy chain isoforms (4) that constitute dis- 
tinct myosin II pools within HUVE cells. 
During the course of these studies, it became apparent 
that  several factors significantly  affected analysis of light 
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Figure 8.  Time course of change in HUVE F-actin content after 
exposure to 1 U/ml thrombin. Monolayers were stimulated for 30, 
60, 90 s, 2.5, 5, 10, 15, 30, and 60 min, fixed, permeabilized,  and 
stained  with rhodamine phalloidin.  F-actin  content was normal- 
ized to total cellular DNA as outlined in Materials and Methods. 
Results are expressed as relative F-actin content (RFC); the ratio 
of fluorescent  intensity  (FI) of stimulated  cultures to fluorescent 
intensity  of control  cultures  (RFC  =  Flthrombin/Fleontrol).  Each 
point is the mean -+ SE of six separate experiments. 
chain phosphorylation in HUVE monolayers. To obtain 
reliable analysis of light chain phosphorylation, the follow- 
ing  conditions  had  to be rigorously controlled:  (a)  post 
confluence  of  HUVE  monolayers  for  at  least  5  d;  (b) 
maintenance of monolayers at 37°C before and during ex- 
periments; and (c) reextraction of the 132,000-g pellet to 
remove all phosphorylated myosin II. 
Investigations of the mechanism of smooth muscle con- 
traction  have  shown  that  agonist  stimulation  elicits  in- 
creases in intracellular Ca  2÷, myosin light chain phosphor- 
ylation,  and  force  and  that  the  former  subsequently 
decline to low levels while developed force is maintained. 
In smooth muscle, force maintenance with reduced light 
chain  phosphorylation  and  maximal  shortening  velocity 
has been referred to as the "latch state" and several stud- 
ies  (15,  24,  57)  suggest  that it results from attached  de- 
phosphorylated myosin crossbridges, i.e., latch bridges. It 
is hypothesized that latch bridges detach more slowly than 
phosphorylated  crossbridges  and  thus  may  account  for 
maintenance of force at low levels of myosin light chain 
phosphorylation (21, 24, 57). 
In this study, the results of a comparison of the stoichi- 
ometry of myosin light chain phosphorylation and isomet- 
ric tension is inconsistent with a latch state as the basis for 
isometric  tension  maintenance  in  thrombin  stimulated 
HUVE  monolayers.  Our  data  is  more  consistent  with 
maintenance of maximally phosphorylated crossbridges in 
the presence of a persistent signal. Reduction in tension is 
associated with a reduction of phosphorylated crossbridges. 
Though speculative, this explanation could account for the 
sustained tension induced by thrombin. 
Initial experiments used [32p]orthophosphoric acid-labeled 
monolayers to analyze light chain phosphorylation. An un- 
expected finding was the difference in quantitative phos- 
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Figure 9.  Time course of cytoplasmic myosin II association with 
the detergent insoluble  cytoskeleton.  HUVE monolayers were 
exposed to thrombin for the indicated  time periods,  permeabi- 
lized  in  buffer B,  and processed as  outlined  in Materials  and 
Methods.  Cytoplasmic myosin II content was assessed by West- 
ern blotting using affinity-purified rabbit anti human platelet my- 
osin II heavy chain antibodies. Detergent insoluble cytoskeletons 
were flooded with 10 mM EDTA, pH 12.3, for determination of 
DNA content.  Cytoplasmic  myosin  II content in unstimulated 
cultures was designated  as 1.0 and loss of myosin II from the solu- 
ble fraction used as a measure of myosin II association with the 
cytoskeleton.  All data was normalized to DNA content and ex- 
pressed as relative soluble  myosin content as described  in text. 
Each point is the mean +__ SE of seven separate experiments. 
phorylation data obtained with [32p]orthophosphoric acid 
and  [35S]methionine  in  vivo  labeling  protocols.  Time 
course experiments using [32p]orthophosphoric acid-labeled 
cultures  showed peak phosphorylation at 2.5  min with a 
50% decline by 30 min (data not shown). In contrast, peak 
phosphorylation  in  [35S]methionine-labeled  cultures  oc- 
curred at 60 s and was sustained for at least 30 min (Table 
II). Although there is no clear-cut explanation, the experi- 
mental  conditions  may  account  for  these  discrepancies. 
Since  HUVE  cells  are  extremely sensitive to  prolonged 
exposure to phosphate-free media as well as high concen- 
trations  of  [32p]orthophosphoric  acid,  radiolabeling  was 
performed in  low  phosphate  media.  This  may interfere 
with either or both radiolabeling of ATP pools or mainte- 
nance of cellular ATP at a high specific activity for pro- 
longed periods. To provide a reliable measure of the phos- 
phorylation  status  of  myosin  II  over  time,  the  specific 
activity of the ATP pool used for phosphorylation must be 
constant. Changes in the specific activity or in the absolute 
ATP  levels  under  the  conditions  used  for these  experi- 
ments could result in artifactual reduction in apparent phos- 
phorylation. The physical separation  of the  [35S]-labeled 
phosphorylated forms is expected to be far more reliable 
because of the stability of the label. 
Unstimulated  monolayers  exhibit  constitutively  phos- 
phorylated  light  chains  with  57%  un-,  32%  mono-,  and 
11% diphosphorylated. Upon treatment with thrombin, a 
shift to the mono- and diphosphorylated light chains  re- 
sults and by 60 s the diphosphorylated (66%) light chains 
of both isoforms predominate. If HUVE tension develop- 
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would  predict  a  close  relationship  between  light  chain 
phosphorylation and  isometric tension,  and  indeed  our 
data show that the presence of mono- and diphosphory- 
lated light chains correlates with the time course of iso- 
metric tension development. Of interest is the fact that the 
persistence of diphosphorylated myosin II light chains par- 
allels the time course of sustained isometric tension, and 
light  chain  dephosphorylation is  accompanied by  a  de- 
crease  in  isometric  tension.  Thus  it  appears  that  the 
diphosphorylated state of myosin light chains may be nec- 
essary for the maintenance of sustained HUVE isometric 
tension in contrast to smooth muscle. 
Studies in vivo (8, 9, 11, 23) and in vitro (12, 31-33) have 
characterized site specific phosphorylation of myosin light 
chains, however, the functional significance of differential 
phosphorylation in vivo is  unclear. Both smooth muscle 
and nonmuscle myosin II have multiple phosphorylation 
sites in their regulatory light chains. Two sites, the Ser-19 
and Thr-18 residues, are phosphorylated by MLCK. The 
preferred site for MLCK phosphorylation is Ser-19,  how- 
ever, with high concentrations of MLCK, Thr-18  is also 
phosphorylated. The kinetics of site phosphorylation for 
both isolated light chains and intact myosin II are consid- 
erably different with Ser-19  500-fold more readily phos- 
phorylated than Thr-18 (31, 33). Monophosphorylation by 
MLCK at Ser-19 in vitro has been shown to increase the 
actin-activated ATPase activity (1, 31-33), regulate myo- 
sin II filament assembly (12, 27, 32) and initiate motor ac- 
tivity of purified myosin in an in vitro motility assay (67). 
Diphosphorylation at  Ser-19/Thr-18  increases  myosin II 
filament stability and further increases actin-activated ATP- 
ase activity above that attributed to monophosphorylation 
at Ser-19, although there is no greater movement of diphos- 
phorylated myosin in an in vitro motility assay (67).  It is 
generally accepted that phosphorylation of myosin II light 
chains at Ser-19 by MLCK is responsible for the initiation 
of smooth muscle contraction. In  smooth muscle tissue 
treated with high concentrations of carbachol  (9)  or by 
neuronal stimulation (52),  low levels of diphosphorylated 
myosin light chains are found transiently (11 and 5%, re- 
spectively) and are considered physiologically insignificant 
in terms of smooth muscle contraction. Furthermore, stud- 
ies  in  permeabilized  smooth  muscle  preparations  have 
shown that monophosphorylation at Ser-19 produces max- 
imal force and additional phosphorylation at Thr-18 does 
not augment force development (23). In contrast to in vitro 
studies and smooth muscle contraction, in nonmuscle cells 
there is evidence of functional significance of diphosphory- 
lation of myosin II. Studies examining activation of secre- 
tory processes in RBL-2H3 cells (8, 48) and platelets (34) 
suggest that diphosphorylation of myosin light chains cor- 
relates with cellular shape change and exocytosis. Likewise 
in HUVE, although the initial rise in tension is associated 
with  monophosphorylation,  development,  and  mainte- 
nance of tension correlates with sustained diphosphoryla- 
tion. To identify the phosphorylation sites of myosin light 
chains in HUVE monolayers stimulated by thrombin, phos- 
phopeptides were analyzed by one-dimensional isoelectric 
focusing  (14,  54).  Constitutive  phosphorylation is  cata- 
lyzed by MLCK in unstimulated cultures and consists of 
both mono- (Ser-19)  and diphosphorylated (Ser-19/Thr-18) 
light chains. During thrombin stimulation, phosphoryla- 
tion of myosin light chains is also catalyzed by MLCK with 
predominance  of  the  diphosphopeptide,  Ser-19/Thr-18. 
Throughout the time course of thrombin stimulation, no 
additional sites or switching of phosphorylation sites were 
detected as shown in antigen induced RBL-2H3 exocytosis 
(8, 48) or during the induction of cytokinesis (59, 76). 
Moy et al. (53) investigating the effects of the inflamma- 
tory  mediator  histamine  on  HUVE  myosin light  chain 
phosphorylation, showed that histamine had a transient ef- 
fect on light chain phosphorylation increasing phosphory- 
lation by 0.18 mol POa/mol MLC that waned to baseline 
levels within 5 min. It is difficult to compare their studies 
with ours in view of the different agonists employed. It is 
also conceivable that these investigators have significantly 
underestimated the degree of light chain phosphorylation 
by not measuring the phosphorylated light chains in the 
100,000-g pellet. 
Having demonstrated that  isometric tension  develop- 
ment paralleled myosin light chain phosphorylation, we 
examined thrombin-induced HUVE cytoskeletal changes. 
We first investigated morphologically the time course and 
spatial rearrangements of F-actin and myosin II and then 
quantitated  the  cytoskeletal  redistributions.  Thrombin 
stimulation causes  polymerization of actin  that  initially 
forms  a  fine  network  that  progressively  organizes  into 
thick stress fibers that arrange parallel to one another. My- 
osin II changes from a diffuse amorphous pattern to orga- 
nize in concert with actin filaments. The majority of solu- 
ble  myosin  II  associates  with  the  detergent  insoluble 
cytoskeleton within 30 s. These data provide quantitative 
evidence that actin polymerization and myosin II filament 
formation occur simultaneously. Thrombin promotes the 
formation of individual fiber systems that interconnect to 
initiate and maintain isometric tension. 
Actin polymerization regionally or globally within non- 
muscle cells in response  to  soluble signals provides the 
polymer template  necessary for  cell  shape  change,  cell 
motility  and  phagocytosis.  Signal  transduction  induces 
functionally important actin structures that serve as an in- 
frastructure for the  interaction of cross-linking proteins 
necessary for cellular motile functions. The intent of this 
study was not to probe the mechanism of actin polymer- 
ization  (review  references  10,  36)  however,  these  data 
raise questions that warrant further study: (a) does the en- 
ergy produced from actin polymerization contribute to or 
generate isometric tension (10); (b) does actin polymeriza- 
tion occur solely from G-actin to F-actin or do various cel- 
lular actin pools contribute to the formation of the actin 
network (7, 68); (c) does cross-linking of the actin scaffold 
by actin binding proteins contribute to the maintenance of 
sustained tension (2, 25, 37, 62); and (d) is tension devel- 
opment a result of actin rearrangements or does tension 
dictate the reorganization of actin filaments? 
Studies of the  assembly properties  of myosin II have 
consistently shown that myosin assembly and enzymatic 
activity are linked (27, 32). Our data from fluorescent im- 
ages coupled with the myosin II association results impli- 
cates myosin II light chain phosphorylation as the critical 
event that initiates myosin II redistribution. Both morpho- 
logical and quantitative data correlate temporally with the 
appearance of mono- and diphosphorylated light chains. It 
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tiates myosin binding to actin (2, 66). This would account 
for the dramatic drop in soluble myosin upon stimulation. 
As diphosphorylated myosin II comes to predominate, fil- 
aments  polymerize  and  stabilize  leading  to  the  periodic 
distribution visualized fluorescently. 
In conclusion, we propose that phosphorylation of myo- 
sin II light chains by MLCK is responsible for the throm- 
bin induced increase in HUVE isometric tension. Mono- 
phosphorylation  at  Ser-19  precedes  the  development  of 
tension while the rise and maintenance  of sustained  ten- 
sion  correlates  with diphosphorylation  at  Ser-19/Thr-18. 
Since  both  activation/polymerization  and  reorganization 
of actin  and myosin  II occur concurrently,  it  is possible 
that the organizing actin network facilitates myosin II fila- 
ment  formation  (2,  50)  that  in turn  causes  cross-linking 
and bundling of the actin network into actomyosin fibrils. 
The resulting rigid cross-linked actomyosin network would 
have an increased capacity to transduce agonist stimulated 
tension. 
Regulation of contractility in nonmuscle cells has been 
assumed to be akin to the smooth muscle paradigm.  Our 
studies  from permeabilized  endothelial  cell preparations 
(73,  74)  also suggested  that  this model was appropriate, 
however, data presented here demonstrates that whereas 
myosin  light  chain  phosphorylation  may  be  a  common 
component of smooth muscle and HUVE monolayer con- 
traction, the mechanism responsible for sustained tension 
in HUVE monolayers cannot be modeled in terms of the 
"latch state."  Therefore  we speculate  that  sustained  iso- 
metric tension in HUVE monolayers results from mainte- 
nance  of diphosphorylated  (Ser-19/Thr-18)  myosin  light 
chains (phosphorylated latch bridges) and that reversal of 
diphosphorylation is associated with a decline in tension. 
In parallel,  agonist activation promotes  growth of a fila- 
mentous cytoskeleton that facilitates the function of myo- 
sin II as a tension-generating molecule. Modulation of this 
network with actin binding proteins (25, 37, 38, 62) could 
significantly  amplify  developed  tension.  Although  these 
studies provide considerable evidence for the role of diphos- 
phorylated  myosin  light  chains  in  the  development  and 
maintenance  of isometric tension in HUVE cells, further 
investigations  are essential to more fully define the rela- 
tionship between myosin light chain phosphorylation states 
and modulations in isometric tension. 
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